International Archives of

Clinical PharmacologyISSN: 2572-3987

Current Issue

 Open Access DOI:10.23937/2572-3987.1510023

Chronic Use of Azithromycin Might Explain the Low Prevalence of COVID-19 in Cystic Fibrosis Patients

Sara Galimberti

Article Type: Opinion | First Published: June 29, 2020

Severe Acute Respiratory Syndrome - Coronavirus 2 (SARS-CoV-2) is the virus responsible for the pandemic that in the first months of 2020 caused worldwide more than 8 millions of infected subjects and 436,000 deaths. It has been reported that only few individuals affected by cystic fibrosis (CF) developed the clinical manifestations of the often dramatic SARS-CoV-2 related disease, now known as Coronavirus Disease 19 (COVID-19)....

 Open Access DOI:10.23937/2572-3987.1510022

Serum Copeptin Levels in Obstructive Sleep Apnea

Ebru Sengul Parlak, MD, Habibe Hezer, MD, Emine Arguder, MD, Hatice Kilic, MD, Murat Alisik, MD, Gokhan Yalciner, MD, Mehmet Ali Babademez, MD, Ozcan Erel, MD and Hatice Canan Hasanoglu, MD

Article Type: Research Article | First Published: January 08, 2020

Obstructive sleep apnea (OSA) is an important public health concern with numerous consequences at the societal level, including motor vehicle accidents, increased cardiovascular morbidity, metabolic dysfunction, and behavioral and cognitive deficit. OSA is characterized by a decrease in, or complete cessation of, airflow despite ongoing efforts to breathe, and is related to oxygen desaturation and sleep fragmentation. The prevalence of OSA has been estimated at 14% in men and 5% in women...

 Open Access DOI:10.23937/2572-3987.1510021

Strategic Framework to Promote Rationale Use of Medicine in Lmics: A Policy Perspective

Sathyanarayana Tamysetty

Article Type: Review Article | First Published: January 06, 2020

Through the application of a strategic framework, the paper attempts to sharpen the focus, coordination and dissemination of promotion of rational use of medicines (PRUM) framework. The purpose of this strategic framework is to guide and organize the systematic planning, implementation, and evaluation of irrational use of medicines and other efforts aimed at improving rational use of medicines and reducing and, ultimately, eliminating irrational use of medicines. The suggested framework efforts ...

Volume 6
Issue 1